The ATP Study: Autologous platelet-leucocyte rich plasma treatment in achillestendinopathy to speed up healing and shorten the return to activity time.

Completed

• Conditions: achilles tendonitis/tendinosis; Achillestendinopathy; 10043237

• Registration Number: NL-OMON33326
• Lead Sponsor: Catharina-ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 126

Inclusion Criteria

Clinical diagnosis of Achillestendinopathie (see also page 16 of protocol).
Established diagnosis of maximum 3 months.

Exclusion Criteria

Tendonruptures
History of ankle or Achillestendon operation
Other explanations for pain Achillestendon (i.e. arthritis)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Earlier return to sport and daily-activities, based upon the VISA-A score.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Pain assessment, patient satisfaction, recurrence rate and ultrasound control</p><br>